Saturday 17 October 2026
Export XRAY’s income statement to Excel — free account
DENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue fell 4.06%, EPS grew 181.8%, free cash flow grew 252.9% and total debt fell 10.0%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
8.57
0.26
−2.94%
Follow XRAY
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
28.88 | 0.00 | 0.00 | 47.96 | 0.00 | 29.06 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 5 | 8 | 3 | 9 | 5 | 5 | 4 | 6 |
P/S ratio |
3.41 | 3.86 | 2.09 | 3.14 | 3.44 | 2.88 | 1.80 | 1.91 | 1.02 | 0.62 |
Altman Z-Score |
3.24 | 2.74 | 1.82 | 3.13 | 2.15 | 2.70 | 1.38 | 1.74 | 0.59 | 0.50 |
Altman Z″-Score (non-manufacturers) |
4.42 | 2.24 | 1.90 | 3.10 | 1.89 | 2.63 | 1.04 | 1.35 | (0.79) | (0.30) |
P/FCF ratio |
29.23 | 33.61 | 26.00 | 24.71 | 20.61 | 23.89 | 19.41 | 33.87 | 13.97 | 23.02 |
Beneish M-Score |
(1.78) | (3.50) | (3.40) | (2.44) | (3.01) | (2.48) | (3.68) | (2.69) | (3.94) | (3.03) |
P/Operating CF |
57.46 | 67.29 | 41.24 | 41.33 | 43.47 | 54.89 | 49.61 | 47.21 | 44.33 | 22.57 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 22 |
P/B ratio |
1.57 | 2.32 | 1.63 | 2.48 | 2.33 | 2.44 | 1.85 | 2.29 | 1.98 | 1.70 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.71 | 4.18 | 2.41 | 3.39 | 3.90 | 3.25 | 2.17 | 2.27 | 1.36 | 1.08 |
EV/EBITDA |
19.03 | 40.95 | 20.78 | 20.20 | 26.67 | 14.42 | 14.72 | 16.42 | 21.28 | 8.72 |
EV/Operating CF |
24.68 | 27.73 | 19.20 | 21.37 | 20.06 | 20.94 | 16.45 | 23.91 | 11.22 | 16.89 |
EV/FCF |
31.81 | 36.42 | 29.91 | 26.72 | 23.37 | 26.98 | 23.43 | 40.43 | 18.73 | 40.08 |
Quick Ratio |
1.33 | 1.12 | 1.00 | 1.19 | 0.81 | 0.86 | 0.85 | 0.72 | 0.52 | 0.76 |
Current Ratio |
2.27 | 2.10 | 1.86 | 2.01 | 1.31 | 1.47 | 1.62 | 1.38 | 1.10 | 1.51 |
Net Debt/EBITDA |
1.54 | 3.17 | 2.72 | 1.52 | 3.16 | 1.65 | 2.53 | 2.66 | 5.41 | 3.71 |
Debt/Assets |
13.08% | 15.53% | 18.01% | 16.66% | 21.16% | 20.71% | 23.89% | 24.37% | 27.57% | 37.12% |
Debt/Equity |
0.19 | 0.24 | 0.30 | 0.28 | 0.40 | 0.38 | 0.48 | 0.55 | 0.82 | 1.50 |
Asset Turnover |
0.47 | 0.36 | 0.42 | 0.47 | 0.37 | 0.46 | 0.46 | 0.53 | 0.58 | 0.66 |
Operating CF/Net income |
1.31 | (0.39) | (0.49) | 2.50 | (8.89) | 1.60 | (0.54) | (2.86) | (0.51) | (0.39) |
Capex/Depreciation |
(0.44) | (0.07) | (0.13) | (0.38) | (0.18) | (0.41) | (0.10) | (0.23) | (0.16) | (0.15) |
Interest Coverage |
12.67 | (40.79) | (25.89) | 13.07 | (0.07) | 9.97 | (14.42) | (1.05) | (12.74) | (4.80) |
| 8.22% | (21.01%) | (17.19%) | 5.01% | (1.46%) | 8.28% | (21.57%) | (3.72%) | (34.75%) | (36.43%) | |
| 5.39% | (14.14%) | (10.61%) | 2.96% | (0.81%) | 4.42% | (11.25%) | (1.76%) | (13.87%) | (10.70%) | |
ROIC |
3.07% | (12.33%) | (9.37%) | 3.60% | (0.03%) | 5.78% | (11.11%) | (1.12%) | (16.87%) | (8.71%) |
Return on Tangible Assets |
24.21% | (80.56%) | (57.93%) | 14.17% | (6.00%) | 30.13% | (64.02%) | (9.79%) | (98.59%) | (38.81%) |
Average Days of Receivables |
61.98 | 68.20 | 64.27 | 70.97 | 72.91 | 64.70 | 58.82 | 63.98 | 53.50 | 68.24 |
Research and Development Expense of Revenue |
3.44% | 3.81% | 4.04% | 3.56% | 3.68% | 4.04% | 4.44% | 4.64% | 4.35% | 4.08% |
Selling, General and Administrative Expense of Revenue |
40.66% | 41.94% | 43.13% | 39.46% | 38.99% | 36.66% | 40.52% | 40.68% | 42.31% | 39.08% |
Intangible Assets out of Total Assets |
0.77 | 0.71 | 0.67 | 0.65 | 0.69 | 0.68 | 0.60 | 0.56 | 0.49 | 0.39 |
Share Based Compensation of Revenue |
1.10% | 1.20% | 0.53% | 1.64% | 1.41% | 1.13% | 1.50% | 1.16% | 1.03% | 0.90% |
Graham Net Nets |
(0.13) | (0.11) | (0.20) | (0.12) | (0.23) | (0.20) | (0.28) | (0.28) | (0.54) | (0.91) |
Graham Number |
41.26 | 0.00 | 0.00 | 24.62 | 0.00 | 31.44 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.46% | (10.25%) | (12.04%) | 2.09% | (0.71%) | 3.44% | (13.58%) | (1.71%) | (23.97%) | (26.25%) |
Free Cash Flow Yield |
3.42% | 2.98% | 3.85% | 4.05% | 4.85% | 4.19% | 5.15% | 2.95% | 7.16% | 4.34% |
Revenue per Share |
17.18 | 17.41 | 17.77 | 18.03 | 15.23 | 19.37 | 18.20 | 18.70 | 18.67 | 18.46 |
Operating CF per Share |
2.58 | 2.62 | 2.23 | 2.86 | 2.96 | 3.01 | 2.40 | 1.78 | 2.27 | 1.18 |
Capex per Share |
(0.56) | (0.63) | (0.80) | (0.55) | (0.40) | (0.65) | (0.69) | (0.70) | (0.89) | (0.66) |
Free Cash Flow per Share |
2.03 | 2.00 | 1.43 | 2.31 | 2.56 | 2.36 | 1.71 | 1.08 | 1.38 | 0.52 |
Cash per Share |
1.76 | 1.40 | 1.38 | 1.82 | 2.00 | 1.55 | 1.69 | 1.58 | 1.34 | 1.63 |
Shareholders Equity per Share |
37.27 | 28.89 | 22.88 | 22.84 | 22.51 | 22.88 | 17.69 | 15.54 | 9.56 | 6.72 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
37.27 | 28.89 | 22.88 | 22.84 | 22.51 | 22.88 | 17.69 | 15.54 | 9.56 | 6.72 |
Free Cash Flow |
442.30 | 458.30 | 321.00 | 516.00 | 562.00 | 515.00 | 368.00 | 228.00 | 281.00 | 104.00 |
Working Capital |
975.90 | 1,048.00 | 874.70 | 1,005.00 | 426.00 | 591.00 | 723.00 | 548.00 | 157.00 | 680.00 |
Capital Expenditures |
(121.10) | (143.60) | (179.00) | (123.00) | (87.00) | (142.00) | (149.00) | (149.00) | (180.00) | (131.00) |
Net Current Asset Value |
(1,686.40) | (1,744.10) | (1,666.00) | (1,508.00) | (2,617.00) | (2,390.00) | (1,938.00) | (2,103.00) | (2,064.00) | (2,066.00) |
EV/EBIT |
30.58 | 0.00 | 0.00 | 38.68 | 0.00 | 22.63 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.04 |
Price to Operating Income |
28.10 | 0.00 | 0.00 | 35.77 | 0.00 | 20.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.35 | 2.25 | 1.63 | 0.40 | 0.62 | 0.45 | 1.99 | 0.79 | 1.46 | 1.02 |
Cash ROIC |
4.41% | 5.35% | 4.58% | 7.44% | 7.65% | 7.10% | 6.13% | 4.20% | 7.39% | 2.83% |
Accounts Receivable Turnover |
7.23 | 5.78 | 5.51 | 5.42 | 4.61 | 5.97 | 5.68 | 5.98 | 6.06 | 5.92 |
Accounts Payable Turnover |
9.78 | 7.11 | 6.75 | 6.28 | 5.52 | 6.68 | 6.64 | 6.43 | 6.72 | 6.80 |
Inventory Turnover |
4.07 | 3.17 | 3.14 | 3.20 | 3.24 | 3.80 | 3.14 | 3.00 | 3.09 | 3.05 |
Average Days of Payables |
46.66 | 57.51 | 54.03 | 60.51 | 65.50 | 50.76 | 56.73 | 59.25 | 47.94 | 59.51 |
Days of Inventory on Hand |
108.20 | 126.01 | 113.97 | 110.40 | 103.23 | 99.77 | 127.50 | 121.21 | 112.19 | 127.35 |
Average Receivables |
517.95 | 691.10 | 724.05 | 741.95 | 724.50 | 708.50 | 691.00 | 663.50 | 625.50 | 622.00 |
Average Payables |
178.30 | 253.70 | 284.15 | 295.95 | 305.00 | 282.00 | 270.50 | 292.00 | 273.00 | 270.50 |
Average Inventory |
428.75 | 570.10 | 611.00 | 580.45 | 519.00 | 495.50 | 571.00 | 625.50 | 594.00 | 603.00 |
Average Assets |
7,979.35 | 10,965.15 | 9,530.75 | 8,645.00 | 8,976.50 | 9,294.50 | 8,441.00 | 7,506.50 | 6,561.50 | 5,591.00 |
Average Common Equity |
5,232.65 | 7,376.90 | 5,880.45 | 5,114.00 | 5,015.00 | 4,966.00 | 4,404.50 | 3,553.00 | 2,618.50 | 1,641.50 |
Columns are period end dates